HUTCHMED (China) Limited
HCM
$14.20
-$0.10-0.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -12.96% | -18.66% | -23.24% | -24.04% | -24.80% |
| Total Other Revenue | -- | -273.96% | -273.96% | -273.96% | -- |
| Total Revenue | -12.96% | -7.28% | -1.41% | -14.94% | -24.80% |
| Cost of Revenue | -13.61% | -15.27% | -16.68% | -17.50% | -18.28% |
| Gross Profit | -7.72% | 440.70% | 213.30% | 18.13% | -54.33% |
| SG&A Expenses | -8.75% | -15.23% | -21.18% | -18.08% | -15.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.80% | -13.94% | -15.00% | -16.47% | -17.78% |
| Operating Income | 10.40% | 64.22% | 83.69% | 38.10% | -337.85% |
| Income Before Tax | 1,049.29% | 13,412.02% | 1,525.07% | 752.77% | -57.04% |
| Income Tax Expenses | 784.45% | 1,005.49% | 1,346.26% | 713.82% | 59.50% |
| Earnings from Continuing Operations | 1,099.19% | 23,008.94% | 1,207.73% | 758.84% | -62.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -86.62% | -643.07% | -383.68% | -1,392.00% | -40.45% |
| Net Income | 1,111.03% | 21,882.39% | 1,212.42% | 758.04% | -62.56% |
| EBIT | 10.40% | 64.22% | 83.69% | 38.10% | -337.85% |
| EBITDA | 17.57% | 76.44% | 93.20% | 53.51% | -217.99% |
| EPS Basic | 1,105.88% | 20,826.92% | 1,202.83% | 741.43% | -62.98% |
| Normalized Basic EPS | -17.13% | 466.67% | 294.78% | 36.82% | -55.96% |
| EPS Diluted | 1,200.50% | 11,039.58% | 1,168.55% | 837.50% | -63.77% |
| Normalized Diluted EPS | -16.95% | 510.00% | 287.18% | 41.94% | -55.30% |
| Average Basic Shares Outstanding | 0.34% | 0.27% | 0.19% | 0.43% | 0.67% |
| Average Diluted Shares Outstanding | 0.01% | 0.60% | 1.20% | 1.37% | 1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |